Taro Pharmaceutical Industries Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF88.10 | CHF105.00 | 22.16% | 9 | CHF179.76B |
| ALC | Alcon | Outperform |
8
|
CHF72.50 | CHF90.64 | 32.91% | 3 | CHF35.76B |
| VTRS | Viatris Inc | Hold |
8
|
$11.82 | $11.73 | 5.75% | 5 | $13.74B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.60 | £28.11 | 49.03% | 9 | £4.35B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$33.43 | $44.75 | 19.65% | 0 | $4.43B |
| PBH | Prestige Consumer Healthcare | Outperform |
16
|
$70.00 | $71.50 | 6.43% | 3 | $3.48B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.52 | $9.50 | 26.33% | 5 | $3.21B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.65 | $6.13 | 20.30% | 1 | $2.09B |
| VNDA | Vanda Pharmaceuticals | Outperform |
0
|
$4.84 | $4.25 | 7.64% | 0 | $284.01M |